India’s longevity market moves from niche wellness to mainstream preventive health

A growing 60+ population, high adoption of digital health tools and rising demand for diagnostics, supplements and personalised programmes are expanding India’s longevity economy. Players including Outlive India, Decode Age, hospitals and health-tech firms are building consumer-facing offerings.

— Source published Sat, 15 Aug, 2026, 23:22 IST · First seen Sun, 16 Aug, 2026, 06:49 IST · Source Financial Express · BrandWagon

What happened

Outlive India · India’s growing senior population and preventive-health focus are creating a longevity consumer market spanning supplements, diagnostics,

Key facts

  • Nearly half of Indians take concrete steps toward healthy ageing, versus 12% globally
  • 71% of Indians use digital tools, wearables or AI-supported health solutions, versus 55% globally
  • India's population aged 60+ is 153 million and projected to reach 347 million by 2050
  • India longevity and wellness pharmaceutical market projected to grow from $2.15 billion in 2025 to $4.09 billion by 2033, at 8.5% CAGR
  • Deepinder Goyal launched a personally backed $25 million longevity fund
  • Non-communicable diseases account for more than 60% of deaths in India

Why this matters

Prioritise partnerships or acquisitions across diagnostics, digital health, hospitals and evidence-based supplement brands to assemble an end-to-end longevity platform before the category becomes crowded.

What to watch

  • Growth in preventive diagnostic-test volumes and repeat annual testing rates among consumers aged 45+.
  • Insurance or employer coverage for health screenings, nutrition coaching and chronic-disease prevention programmes.
  • Regulatory action on nutraceutical, anti-ageing and personalised-health claims.
  • Consumer willingness to pay for recurring memberships versus one-off diagnostic packages.
  • Hospital, pharmacy-chain and e-commerce launches of longevity-focused care bundles.
  • Adoption of wearables, digital health records and AI-led risk scoring among older consumers.
  • Evidence of supplement-category trading up, subscription retention and private-label penetration.
  • Launch tiered preventive-health propositions: low-cost annual screening, mid-tier subscriptions and premium personalised programmes.
  • Build trusted bundles across diagnostics, pharmacy, nutrition, fitness, mental health and teleconsultation rather than selling supplements as standalone products.
  • Use loyalty and app data to identify 45+ households, caregivers and chronic-risk consumers; market family plans rather than only senior-specific offers.
  • Partner with hospitals, accredited labs and clinicians to validate claims and create referral pathways.
  • Develop private-label supplements and healthy-ageing products with clear ingredient sourcing, dosage guidance and evidence-led positioning.
  • Expand assisted digital journeys through stores, call centres and home sample collection to reduce adoption barriers for older consumers.